Drug application
NYSTATIN (NYSTATIN)
Drugs@FDA ANDA 062876 · TARO
Key facts
| Drug name | NYSTATIN |
|---|---|
| Active ingredients | NYSTATIN |
| Application type | ANDA |
| Application number | 062876 |
| Company | TARO |
| Dosage forms | SUSPENSION, ORAL |
| Strength | 100,000 UNITS/ML |
| Marketing status | Discontinued |
| TE codes | AA |
| Reference listed drug | No |
| Latest submission status date | Feb 29, 1988 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.